Skip to main content
OpenTrials
Completed

NCT Number: NCT01269554

Etiology of Diarrhea in Guinea-Bissau and in Finland

Diarrhoea is the leading cause of death in the world with 2.2 million deaths every year. The majority of deaths are among children in developing countries, but the travellers encounter the disease as well. The studies on the aetiology have suffered from serious methodological deficiencies and the results are even controversial. At the same time, the current diagnostic methods are inadequate. The investigators have recently developed novel multiplex RT-PCR methods to cover the majority of diarrhoeal pathogens. The present study is a collaboration between Finland and Sweden/Guinea-Bissau. The aim is to characterize the causative agents of diarrhoea (a) in Finnish volunteers before and after a travel to tropical areas and, (b) in inhabitants of endemic areas in Guinea-Bissau. For these purposes stool samples will be collected from volunteers of different age groups and from healthy volunteers as well as those with diarrhea both in Guinea-Bissau and in Finland. In addition to pathogens, other intestinal microbes and antimicrobial resistance will be investigated

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Postitalo Travel Clinic, Helsinki, Finland

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Accepting to participate and willing to deliver 2 stool samples.
  • With diarrhea: the first 10 children and 10 adults presenting each month at the health facility Without diarrhea: In Bissau matched controls drawn from the registration system at Bandim Health Project. In Finland controls selected at the health facilities participating.

Exclusion criteria

  • Not willing or able to deliver the stool samples

Treatment and study plan

Primary outcomes

  1. Type of pathogens in stool samples in percentage of included patients

    Time frame: 2 years

    The percentage of included patients with different pathogens will be described.

Secondary outcomes

  1. Type of microbes other than than pathogens in stool samples in percentage of included patients

    Time frame: 2 years

  2. The patern of resistance to antimicrobials in isolated pathogens

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Bandim Health Project

Other

Collaborators

  • Stockholm University
  • University of Helsinki

Registry information

Important dates

Study start
2010
Primary completion
2013
Study completion
2015
First posted
Jan 4, 2011
Registry last updated
May 26, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.